Sulfamethoxazole-TMP DS tablet 500S
Ended Awarded Last action
- Contract number
- SPE2DR26F8Y8R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,827
Award facts
- Contract value 100% obligated
- $1,827.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,827.35 to AmerSourceBergen Drug Corp for the supply of Sulfamethoxazole-Trimethoprim DS tablets (500 count) on January 6, 2026, with an ultimate completion date of January 7, 2026. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award through open competition. The place of performance is located in Conshohocken, Pennsylvania, which serves as the vendor's corporate headquarters. This delivery order is a child contract executed under AmerSourceBergen Drug Corp's parent company, Cencora, Inc. (doing business as AmerSourceBergen), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031.
This delivery order represents a routine pharmaceutical procurement supporting the Defense Health Agency and military healthcare systems. Sulfamethoxazole-Trimethoprim is a commonly prescribed antibiotic combination used across military treatment facilities and veteran healthcare programs. The contract structure as a delivery order under the larger IDC demonstrates the efficiency of the standing pharmaceutical supply vehicle, enabling the DLA to rapidly procure essential medications to support military readiness and healthcare operations. AmerSourceBergen's role as a pharmaceutical prime vendor reflects its critical position within the federal medical supply chain, where it distributes a comprehensive range of generic and brand-name medications, vaccines, and medical supplies to government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F8Y8R?
SPE2DR26F8Y8R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F8Y8R worth?
The government has obligated $1,827 on SPE2DR26F8Y8R.
Is contract SPE2DR26F8Y8R an order under another contract?
Yes. SPE2DR26F8Y8R is a delivery order under SPE2DR25D1107, an indefinite delivery contract.
Was contract SPE2DR26F8Y8R competed?
The extent of competition for SPE2DR26F8Y8R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award